Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antitumor Therapy
Recurrent gastrointestinal stromal tumors in complete remission after imatinib treatment
October 5th, 2006
Recurrent gastrointestinal stromal tumors undergo complete remission following treatment with imatinib. "A 49-year-old man underwent partial resection of the jejunum for an abdominal tumor, which was histologically confirmed to be a gastrointestinal stromal tumor (GIST). Immunohistochemistry revealed that the tumor cells were positive for c-kit, p52, and MIB-1," scientists in Japan report. According to M. Kobayashi and colleagues Kochi Medical School, "He underwent resection of a total of 83 recurrent tumors over the next 36 months. A computed tomography (CT) scan done a few months later showed multiple tumor recurrences." "The...
Source: Blood Weekly (2006-10-05)
|
